Abiraterone | CB-7598 | Androgen | P450 | AmBeed-信号通路专用抑制剂

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]}	现货	1周咨询	- +

Cell Line 22Rv1 cells VCaP cells C4-2-AbiR cells C4-2 cells	Concentration	Treated Time	Description	References
22Rv1 cells	20 µM	24 hours	To investigate the effect of Abiraterone on SLCO1B3 expression, results showed that Abiraterone significantly upregulated SLCO1B3 expression.	Sci Rep. 2021 May 24;11(1):10765.
VCaP cells	20 µM	24 hours	To investigate the effect of Abiraterone on SLCO1B3 expression, results showed that Abiraterone significantly upregulated SLCO1B3 expression.	Sci Rep. 2021 May 24;11(1):10765.
C4-2-AbiR cells	0.5 µM to 25 µM	6 monthourss	Establishment of the abiraterone-resistant cell line C4-2-AbiR and validation of the role of KAT2A in abiraterone resistance.	Cell Death Dis. 2021 Aug 12;12(8):787.
C4-2 cells	0.5 µM to 25 µM	6 monthourss	Validation of the effect of KAT2A overexpression on abiraterone resistance in C4-2 cells.	Cell Death Dis. 2021 Aug 12;12(8):787.

Species Mice BALB/c mice	Animal Model 22Rv1 xenograft model Abiraterone-resistant CRPC model	Administration	Dosage	Frequency	Description	References
Mice	22Rv1 xenograft model	Intraperitoneal injection	5 mmol/kg/day	Once daily for 5 or 15 days	To evaluate the effect of Abiraterone on SLCO1B3 expression in vivo, results showed that Abiraterone significantly upregulated SLCO1B3 expression.	Sci Rep. 2021 May 24;11(1):10765.
BALB/c mice	Abiraterone-resistant CRPC model	Oral	60 mg/kg	Twice a week for approximately 40 days	Validation of whether KAT2A knockdown can reverse abiraterone resistance in vivo.	Cell Death Dis. 2021 Aug 12;12(8):787.

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT01017939	Prostate Neoplasms	Phase 1	Completed	-	United States, California ... 展开 >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211 Beverly Hills, California, United States United States, Texas START - South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States, 78229 San Antonio, Texas, United States Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Vancouver, British Columbia, Canada 收起 <<
NCT03748641	Metastatic Prostate Cancer	Phase 3	Not yet recruiting	February 25, 2025	-
NCT02090114	Prostate Cancer	Phase 2	Recruiting	April 2019	United States, Maryland ... 展开 >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Irina Rifkind, RN, MSN 410-502-2043 irifkin1@jhmi.edu Contact: Rana Sullivan, RN, BSN 410-614-6337 tomalra@jhmi.edu Principal Investigator: Samuel Denmeade, MD 收起 <<
NCT02867020	Prostate Cancer	Phase 2	Recruiting	January 2020	Brazil ... 展开 >> Clínica AMO Recruiting Salvador, Bahia, Brazil Contact: Bruno Setenta Principal Investigator: Vanessa Dybal, MD CRIO Recruiting Fortaleza, Ceará, Brazil Contact: Monica Gomes Principal Investigator: Eduardo Cronemberger, MD CPO - Pucrs Recruiting Porto Alegre, Rio Grande do Sul, Brazil Contact: Virginia Webber Principal Investigator: André Fay, MD Oncologia Rede D'Or S.A. Recruiting Rio de Janeiro, RJ, Brazil, 22281 100 Contact: Leandro Camara Principal Investigator: Daniel Herchenhorn Hospital de Câncer de Barretos Not yet recruiting Barretos, São Paulo, Brazil Contact: Ana Camila Alfano Principal Investigator: Ricardo Zylberberg, MD Centro de Pesquisa Clínica em Hematologia e Oncologia - CEPHO Not yet recruiting Santo André, São Paulo, Brazil Contact: Andressa Tamashiro Principal Investigator: Daniel Cubero, MD Grupo COI Not yet recruiting Rio de Janeiro, Brazil Contact: Débora Victorino Principal Investigator: Fábio Peixoto, MD Beneficiencia Portuguesa de São Paulo/Hospital São José Not yet recruiting São Paulo, Brazil Contact: Patricia Molina Contact: Daniel Lang Principal Investigator: Fernando Maluf, MD Hospital Israelita Albert Einstein Not yet recruiting São Paulo, Brazil Contact: Roberta Possato Principal Investigator: Oren Smaletz, MD ICESP Not yet recruiting São Paulo, Brazil Contact: Bárbara Penna Principal Investigator: David Muniz, MD 收起 <<
NCT01845792	Prostate Cancer	Phase 2	Terminated(Low accrual)	-	United States, Colorado ... 展开 >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 收起 <<
NCT01553188	Prostatic Neoplasms ... 展开 >> Prostate Cancer Neoplasm, Prostate Neoplasm,Prostatic 收起 <<	Phase 2	Active, not recruiting	January 1, 2019	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 <<
NCT01553188	-		Active, not recruiting	-	-
NCT02160353	High Risk Localised Prostate C... 展开 >>arcinoma 收起 <<	Phase 2	Recruiting	October 2020	Ireland ... 展开 >> Cork University Hospital Recruiting Cork, Ireland Contact: Contact Person 021-4920014 Principal Investigator: Paul Kelly, Dr St Luke's Hospital Recruiting Dublin, Ireland, 6 Contact: Contact Person 01-4065000 Principal Investigator: Pierre Thirion, Dr University Hospital Galway Recruiting Galway, Ireland Contact: Contact Person 091-893487 Principal Investigator: Cormac Small, Dr 收起 <<
NCT01845792	-		Terminated(Low accrual)	-	-
NCT01575587	Pharmacology	Phase 1	Completed	-	United States, California ... 展开 >> Cypress, California, United States 收起 <<
NCT01591122	Prostate Cancer	Phase 3	Active, not recruiting	January 28, 2019	China ... 展开 >> Beijing, China Chengdu, China Chongqing, China Guangzhou, China Hangzhou, China Jinan, China Nanjing, China Shanghai, China Tianjin, China Wuhan, China Malaysia Kuala Lumpur N/A, Malaysia Kuala Lumpur, Malaysia Russian Federation Arkhangelsk, Russian Federation Ekaterinburg, Russian Federation Moscow N/A, Russian Federation Moscow, Russian Federation Pyatigorsk, Russian Federation Rostov-On-Don, Russian Federation Sochi, Russian Federation St.-Petersburg, Russian Federation Stavropol, Russian Federation Ufa, Russian Federation Yoshkar-Ola, Russian Federation Thailand Bangkok, Thailand 收起 <<
NCT00544440	Prostate Neoplasms	Phase 2	Completed	-	United States, Texas ... 展开 >> Houston, Texas, United States 收起 <<
NCT00474383	Prostate Neoplasms	Phase 2	Completed	-	United States, California ... 展开 >> San Francisco, California, United States United States, New York New York, New York, United States United Kingdom Sutton, United Kingdom 收起 <<
NCT00544440	-		Completed	-	-
NCT01681433	Prostate Cancer ... 展开 >> Metastatic Castrate-Resistant Prostate Cancer PSA 收起 <<	Phase 2	Terminated(lack of accrual)	-	United States, California ... 展开 >> Prostate Oncology Specialists, Inc. Marina Del Rey, California, United States, 90292 United States, Indiana IU Health Bloomington Hospital Bloomington, Indiana, United States, 47403 IU Health Goshen Hospital Goshen, Indiana, United States, 46527 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46219 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Mexico University of New Mexico Cancer Center: Albuquerque Albuquerque, New Mexico, United States, 87131 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Canada, Alberta Alberta Health Services: Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Canada, Quebec Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada, H2L 4M1 收起 <<
NCT02218606	Prostate Cancer	Phase 2	Recruiting	August 2019	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Susan Slovin, MD, PhD 646-422-4470 Contact: Howard Scher, MD 646-422-4330 Principal Investigator: Susan Slovin, MD Weill Cornell Medical Center Recruiting New York, New York, United States, 10065 Contact: Ana Molina, MD Principal Investigator: Ana Molina, MD United States, Pennsylvania Thomas Jefferson University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: William Kelly, D.O. Principal Investigator: William Kelly, D.O. United States, Virginia Virginia Oncology Associates Recruiting Norfolk, Virginia, United States, 23502 Contact: Mark Fleming, MD 757-466-8683 Principal Investigator: Mark Fleming, MD 收起 <<
NCT03243604	-		Completed	-	France ... 展开 >> Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière Paris, Ile De France, France, 75013 收起 <<
NCT00474383	-		Completed	-	-
NCT00924469	Prostate Cancer	Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Boston, Massachusetts, United States United States, Texas Houston, Texas, United States United States, Washington Seattle, Washington, United States Wenatchee, Washington, United States 收起 <<
NCT01858441	Pharmacogenetic Study	Not Applicable	Active, not recruiting	December 2020	France ... 展开 >> Centre Antoine Lacassagne Nice, France, 06000 收起 <<
NCT01574937	Prostate Cancer	Phase 1	Active, not recruiting	December 2018	United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT02987543	Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 3	Recruiting	February 5, 2021	-
NCT01692483	-		Withdrawn(Sponsor determined s... 展开 >>tudy is not required according to PFDA Circular 2013-004) 收起 <<	June 2016	-
NCT00473512	Prostatic Neoplasms	Phase 1 Phase 2	Completed	-	United Kingdom ... 展开 >> Sutton, United Kingdom 收起 <<
NCT00924469	-		Completed	-	-
NCT00473512	-		Completed	-	-
NCT01685125	Hormone-resistant Prostate Can... 展开 >>cer Recurrent Prostate Cancer Stage IV Prostate Cancer 收起 <<	Phase 2	Active, not recruiting	March 2018	United States, California ... 展开 >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 收起 <<
NCT01685268	Prostate Cancer	Phase 1 Phase 2	Completed	-	-
NCT03072238	Metastatic Prostate Cancer	Phase 3	Recruiting	November 18, 2023	-
NCT03325127	-		Withdrawn(Project plan changed... 展开 >>, study conduct was no longer needed.) 收起 <<	September 28, 2018	-
NCT01681433	-		Terminated(lack of accrual)	-	-
NCT00485303	-		Completed	-	-
NCT03414034	Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 2	Recruiting	June 11, 2019	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact 617-724-4000 Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact 617-632-9281 Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact 617-632-6328 收起 <<
NCT01995058	Prostate Cancer ... 展开 >> Castration Resistant Prostate Cancer Prostatic Neoplasms 收起 <<	Phase 2	Terminated(Study stopped after... 展开 >> results of cabozantinib Phase 3 CRPC study XL184-307.) 收起 <<	-	United States, Arizona ... 展开 >> Scottsdale, Arizona, United States, 85258 Sedona, Arizona, United States, 86336 Tucson, Arizona, United States, 85710 United States, California Oxnard, California, United States, 93030 San Diego, California, United States, 92108 United States, Colorado Aurora, Colorado, United States, 80012 Aurora, Colorado, United States, 80045 United States, Georgia Athens, Georgia, United States, 30607 Atlanta, Georgia, United States, 30318 United States, Illinois Peoria, Illinois, United States, 61615 United States, Kansas Wichita, Kansas, United States, 67214 United States, Nevada Las Vegas, Nevada, United States, 89148 United States, North Carolina Raleigh, North Carolina, United States, 27607 United States, Oregon Tualatin, Oregon, United States, 97062 United States, South Carolina Charleston, South Carolina, United States, 29414 Greenville, South Carolina, United States, 29605 Myrtle Beach, South Carolina, United States, 29572 United States, Texas Dallas, Texas, United States, 75246 Houston, Texas, United States, 77024 United States, Utah Salt Lake City, Utah, United States, 84112 收起 <<
NCT02257736	Prostatic Neoplasms	Phase 3	Active, not recruiting	August 24, 2021	-
NCT01503229	Hormone-Resistant Prostate Can... 展开 >>cer Metastatic Prostate Carcinoma Recurrent Prostate Carcinoma Stage IV Prostate Adenocarcinoma 收起 <<	Phase 2	Active, not recruiting	September 12, 2019	United States, Washington ... 展开 >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 <<
NCT01309672	Prostate Cancer	Phase 2	Active, not recruiting	October 2018	-
NCT01751451	Prostate Cancer	Phase 2	Active, not recruiting	October 2019	United States, Illinois ... 展开 >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Michigan Karmanos Cancer Institute, Wayne State University Detroit, Michigan, United States, 48201 United States, Nebraska Urology Cancer Center and GU Research Network Omaha, Nebraska, United States, 68130 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 NorthShore University Health System Long Island City, New York, United States Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Cornell Medical Center New York, New York, United States Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27514 Duke University Medical Center Durham, North Carolina, United States, 27701 United States, Oregon Oregon Health & Science University Knight Cancer Institute Portland, Oregon, United States, 97239 收起 <<
NCT02730975	Prostate Cancer	Phase 1	Recruiting	June 2018	Spain ... 展开 >> Hospital Universitario Virgen del Rocío Recruiting Seville, Spain, 41013 Contact: Ignacio Durán Martínez, MD-PhD ignacioduranmartinez@gmail.com Sub-Investigator: Ignacio Durán Martínez, MD-PhD Principal Investigator: Clara Rosso-Fernández, MD-PhD Sub-Investigator: Begoña Pérez-Valderrama, MD-PhD Sub-Investigator: Inmaculada Sánchez-Simón, MD-PhD Sub-Investigator: Carlos Robles Barraza, MD-PhD Sub-Investigator: Patricio Serra, MD-PhD 收起 <<
NCT01946165	Prostate Cancer	Phase 2	Completed	-	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT00485303	Prostatic Neoplasms ... 展开 >> Prostate Cancer 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> UCLA Los Angeles, California, United States, 90024 Los Angeles, California, United States UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 San Francisco, California, United States United States, Maryland John Hopkins Baltimore, Maryland, United States, 21205 Baltimore, Maryland, United States United States, Massachusetts Masachussetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Hospital Boston, Massachusetts, United States, 02215 Boston, Massachusetts, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York, New York, United States United Kingdom Royal Marsden Hospital Sutton, United Kingdom Sutton, United Kingdom 收起 <<
NCT02036060	Metastatic Prostate Cancer	Phase 2	Active, not recruiting	February 2020	Spain ... 展开 >> Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Universitari Germans Trias I Pujol Badalona, Barcelona, Spain, 08916 Consorcio Hospitalario Provincial de Castellón Castellón de la Plana, Castellón, Spain, 12002 Hospital Universitari Son Espases Palma de Mallorca, Islas Baleares, Spain, 07120 Complexo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36036 Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospital Clinic I Provincial de Barcelona Barcelona, Spain, 08036 Complejo Hospitalario Regional Reina Sofía Córdoba, Spain, 14004 Hospital Universitario de Guadalajara Guadalajara, Spain, 19002 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28007 Hospital Ramón Y Cajal Madrid, Spain, 28034 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Virgen de La Victoria Málaga, Spain, 29010 Complejo Hospitalario Regional Virgen Del Rocio Sevilla, Spain, 41013 Fundación Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 收起 <<
NCT01487863	Prostate Cancer Metastatic ... 展开 >> Hormone Refractory Prostate Cancer Castration-resistant Prostate Cancer 收起 <<	Phase 2	Completed	-	United States, California ... 展开 >> UCSD Medical Center - La Jolla La Jolla, California, United States, 92037 Moores UCSD Cancer Center La Jolla, California, United States, 92093 Cancer Center Oncology Medical Group La Mesa, California, United States, 91942 UCSD Medical Center - Hillcrest San Diego, California, United States, 92103 Medical Oncology Associates - SD San Diego, California, United States, 92123 Sharp Rees-Stealy San Diego, California, United States, 92123 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Colorado The Urology Center of Colorado Denver, Colorado, United States, 80211 United States, District of Columbia Georgetown University Medical Center - Lombardi Cancer Center Washington, D.C., District of Columbia, United States, 20007 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maryland Mid Atlantic Urology Associates, Mid Atlantic Clinical Research Greenbelt, Maryland, United States, 20770 United States, Nebraska GU Research Center, LLC Omaha, Nebraska, United States, 68130 United States, New York NYU Clinical Cancer Center, NYU Langone Medical Center New York, New York, United States, 10016 The Mount Sinai Medical Center New York, New York, United States, 10029 Associated Medical Professionals of NY, PLLC Oneida, New York, United States, 13421 Associated Medical Professionals of New York, PLLC Syracuse, New York, United States, 13210 United States, Oregon Providence Cancer Center Oncology and Hematology Care Portland, Oregon, United States, 97213 United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 United States, Tennessee Urology Associates, P.C. Nashville, Tennessee, United States, 37209 United States, Virginia Urology of Virginia Virginia Beach, Virginia, United States, 23462 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 收起 <<
NCT01487863	-		Completed	-	-
NCT01576172	Castration Levels of Testoster... 展开 >>one Castration-Resistant Prostate Carcinoma PSA Progression Recurrent Prostate Carcinoma Stage IV Prostate Cancer AJCC v7 收起 <<	Phase 2	Active, not recruiting	-	United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 United States, Indiana Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 <<
NCT01309672	-		Active, not recruiting	-	-
NCT01715285	Prostate Neoplasms	Phase 3	Active, not recruiting	August 3, 2021	-
NCT02364531	-		Completed	-	-
NCT01715285	-		Active, not recruiting	-	-
NCT01848067	Adenocarcinoma of the Prostate... 展开 >> Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer 收起 <<	Phase 1 Phase 2	Completed	-	United States, Pennsylvania ... 展开 >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 <<
NCT01848067	-		Completed	-	-
NCT01741753	Prostate Cancer	Phase 1	Terminated(Due to slow accrual... 展开 >> the supllier of BKM120 requested that we cease further enrollment.) 收起 <<	-	United States, Massachusetts ... 展开 >> Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 <<
NCT01814865	Post-menopausal ER+ Stage I-II... 展开 >>IA Primary Operable Breast Cancer 收起 <<	Phase 2	Withdrawn(Funding was not acqu... 展开 >>ired) 收起 <<	-	Canada, British Columbia ... 展开 >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 The Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Segal Cancer Centre Montreal, Quebec, Canada, H3T 1E2 收起 <<
NCT02125617	-		Terminated(Poor recruition)	February 2017	Denmark ... 展开 >> University Hospital of Copenhagen, Rigshospitalet Copenhagen, Denmark, 2100 收起 <<
NCT01873001	Healthy Volunteers	Phase 1	Completed	-	Belgium ... 展开 >> Merksem, Belgium 收起 <<
NCT01314118	Prostate Cancer ... 展开 >> Prostatic Neoplasm 收起 <<	Phase 2	Active, not recruiting	July 31, 2022	-
NCT01314118	-		Active, not recruiting	-	-
NCT02913196	Prostate Cancer Metastatic	Phase 1	Recruiting	March 2021	United States, New York ... 展开 >> Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Principal Investigator: Ana M Molina, MD 收起 <<
NCT00910754	Prostate Neoplasms	Phase 1	Completed	-	United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Buffalo, New York, United States United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 Myrtle Beach, South Carolina, United States United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 San Antonio, Texas, United States Canada, British Columbia BC Cancer Agency-Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 Vancouver, British Columbia, Canada 收起 <<
NCT03458247	Prostate Cancer	Phase 2	Recruiting	May 2019	France ... 展开 >> Department of Medical Oncology, Cochin Hospital Recruiting Paris, France, 75014 Contact: jerome Alexandre, Md, PhD +33 1 58 41 19 27 jerome.alexandre@aphp.fr 收起 <<
NCT03279250	Diseases of Male Genital Organ... 展开 >>s Prostate Cancer 收起 <<	Phase 2	Recruiting	October 2021	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations eefstathiou@mdanderson.org 收起 <<
NCT02077634	Prostate Cancer	Phase 2	Active, not recruiting	October 2018	Germany ... 展开 >> Gemeinschaftspraxis für Onkologie Augsburg, Germany, 86150 Gemeinschaftspraxis für Urologie Berlin, Germany, 13187 Urologie Bonn-Rhein-Sieg, Praxis Bad Godesberg Bonn, Germany, 53177 Praxisgemeinschaft für Urologie Borken, Germany, 46325 Urologicum Duisburg Duisburg, Germany, 47179 Urologicum Hamburg Hamburg, Germany, 22399 Universitätsklinikum Homburg/Saar, Klinik für Urologie und Kinderurologie Homburg/Saar, Germany, 66421 Urologische Gemeinschaftspraxis Kempen, Germany, 47906 Facharztpraxis Dr. Klier, Cologne-Study-Group Köln, Germany, 50968 Klinikum Landshut Landshut, Germany, 84034 Urologisches Zentrum Lübeck (UZL) Lübeck, Germany, 23560 Gemeinschaftspraxis PUR-R Mülheim/Ruhr, Germany, 45468 Gemeinschaftspraxis Urologie Pasing München, Germany, 81241 Privatärztliche urologische Studienpraxis Nürtingen, Germany, 72622 Pandamed - Übag Remscheid, Germany, 42853 Zentrum für Onkologie und Urologie Rostock, Wissenschaftskontor Nord GmbH & Co. KG Rostock, Germany, 18107 Praxisgemeinschaft für Onkologie und Urologie Wilhelmshaven, Germany, 26389 Praxisgemeinschaft Wolfsburg, Germany, 38440 DGU Wuppertal, Germany, 42103 Pandamed - Übag Wuppertal, Germany, 42103 Praxis für Urologie Würselen, Germany, 52146 Praxis für Urologie Zwickau, Germany, 08060 收起 <<
NCT01994590	Prostate Cancer	Phase 2	Terminated(Sponsor stopped sup... 展开 >>plying study drug) 收起 <<	-	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT01511536	Prostate Cancer	Phase 1 Phase 2	Completed	-	United States, California ... 展开 >> Investigational Site Number 840001 San Francisco, California, United States United States, Connecticut Investigational Site Number 840002 New Haven, Connecticut, United States, 06510 France Investigational Site Number 250001 Villejuif, France, 94805 United Kingdom Investigational Site Number 826001 Sutton, United Kingdom, SM2 5PT 收起 <<
NCT01588782	Healthy Volunteers	Phase 1	Completed	-	Belgium ... 展开 >> Merksem, Belgium 收起 <<
NCT01717053	Prostate Cancer	Phase 2	Active, not recruiting	August 2021	United States, North Carolina ... 展开 >> Durham Regional Hospital Durham, North Carolina, United States, 27704 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<
NCT03418324	Prostate Cancer	Phase 2	Recruiting	January 2021	United States, California ... 展开 >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Hannah Coleman 310-967-4376 hannah.coleman@cshs.org Principal Investigator: Edwin Posadas, MD 收起 <<
NCT02254785	Metastatic Castration-Resistan... 展开 >>t Prostatic Cancer 收起 <<	Phase 2	Active, not recruiting	May 2020	Australia, Victoria ... 展开 >> Box Hill Hospital Box Hill, Victoria, Australia, 3128 Monash Health-Monash Medical Centre Clayton, Victoria, Australia, 3168 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3000 Canada, Alberta Tom Baker Cancer Cantre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Kelowna Kelowna, British Columbia, Canada, V1Y 5J3 BCCA- Vancouver Center Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Durham Regional Cancer Centre (Lakeridge Health) Oshawa, Ontario, Canada, L1G 2B9 The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Canada, Saskatchewan Saskatoon Cancer Center Saskatoon, Saskatchewan, Canada, 27N 4H4 收起 <<
NCT01717053	-		Active, not recruiting	-	-
NCT01543776	Castration-resistant Prostate ... 展开 >>Cancer Stage IV Prostate Cancer 收起 <<	Phase 2	Active, not recruiting	December 2017	United States, Georgia ... 展开 >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637-1470 North Shore University Health System Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60430 Illinois Cancer Care Peoria, Illinois, United States, 61615 Singapore National University Hospital Singapore, Singapore 收起 <<
NCT01517802	Metastatic Castration-resistan... 展开 >>t Prostate Cancer Metastatic Breast Cancer 收起 <<	Phase 3	Active, not recruiting	April 9, 2021	United States, Colorado ... 展开 >> Aurora, Colorado, United States United States, Louisiana Marrero, Louisiana, United States United States, Massachusetts Boston, Massachusetts, United States United States, Nebraska Omaha, Nebraska, United States United States, New York East Setauket, New York, United States New York, New York, United States United States, South Carolina Myrtle Beach, South Carolina, United States United States, Tennessee Chattanooga, Tennessee, United States United States, Texas Dallas, Texas, United States Houston, Texas, United States Australia Kogarah, Australia Kurralta Park, Australia South Brisbane, Australia Subiaco, Australia Belgium Antwerpen, Belgium Germany Hamburg, Germany Spain Barcelona, Spain Sweden Uppsala, Sweden United Kingdom Newcastle Upon Tyne, United Kingdom Northwood, United Kingdom Sutton, United Kingdom Whitchurch, United Kingdom 收起 <<
NCT02353715	-		Active, not recruiting	December 2018	United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 <<
NCT01511536	-		Completed	-	-
NCT01756638	Prostate Cancer	Phase 2	Completed	-	Japan ... 展开 >> Asahi, Japan Fukuoka, Japan Gifu, Japan Kanazawa, Japan Kashiwa, Japan Kita-Gun, Japan Kuki, Japan Kurashiki, Japan Maebashi, Japan Matsuyama, Japan Mitaka, Japan Niigata, Japan Osaka-Sayama, Japan Osaka, Japan Sagamihara, Japan Sakura, Japan Sapporo, Japan Yokohama, Japan Yokosuka, Japan 收起 <<
NCT02807805	Metastatic Prostate Carcinoma ... 展开 >> Recurrent Prostate Carcinoma Stage IV Prostate Cancer 收起 <<	Phase 2	Recruiting	December 2020	United States, California ... 展开 >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Chong-Xian Pan 916-734-3771 cxpan@ucdavis.edu Principal Investigator: Chong-Xian Pan 收起 <<
NCT01715259	Renal Insufficiency	Phase 1	Completed	-	United States, Florida ... 展开 >> Orlando, Florida, United States 收起 <<
NCT02123758	Prostatic Neoplasms ... 展开 >> Metastatic Castration-Resistant Prostate Cancer 收起 <<	Phase 1	Active, not recruiting	June 3, 2019	United States, California ... 展开 >> Los Angeles, California, United States San Francisco, California, United States United States, Texas Houston, Texas, United States Canada, British Columbia Vancouver, British Columbia, Canada Canada, Quebec Montreal, Quebec, Canada Netherlands Rotterdam, Netherlands United Kingdom Sutton, United Kingdom 收起 <<
NCT02097303	-		Completed	-	-
NCT02097303	Prostate Cancer	Phase 2	Completed	-	United States, Maryland ... 展开 >> Chesapeake urology Research Associates Towson, Maryland, United States, 21204 United States, Nebraska Urology Cancer Center and GU Research Network Omaha, Nebraska, United States, 68130 United States, New York Associated Medical Professionals Syracuse, New York, United States, 13210 United States, Oregon Oregon Urology Institute Springfield, Oregon, United States, 97477 United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 收起 <<
NCT03449719	Rate of PSA Response in Oligom... 展开 >>etastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 收起 <<	Not Applicable	Not yet recruiting	May 1, 2022	-
NCT02405858	Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 4	Completed	-	Japan ... 展开 >> Asahi, Japan Higashi-Ibaraki, Japan Kanazawa, Japan Kobe, Japan Koshigaya, Japan Kumamoto, Japan Narashino, Japan Okayama, Japan Sagamihara, Japan Sakura, Japan Shinjuku-Ku, Japan Sunto, Japan Yokohama, Japan Yokosuka, Japan 收起 <<
NCT01640093	Healthy Participants	Phase 1	Completed	-	United States, Arizona ... 展开 >> Tempe, Arizona, United States 收起 <<
NCT01828476	Prostate Cancer	Phase 2	Terminated(The Investigator le... 展开 >>ft the organization.) 收起 <<	-	United States, New Jersey ... 展开 >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 收起 <<
NCT02217566	Prostatic Neoplasms	Phase 2	Active, not recruiting	October 31, 2018	Brazil ... 展开 >> Porto Alegre, Brazil Rio De Janeiro, Brazil Santo Andre, Brazil Sao Paulo, Brazil São Paulo, Brazil 收起 <<
NCT01828476	-		Terminated(The Investigator le... 展开 >>ft the organization.) 收起 <<	-	-
NCT02001571	Prostate Cancer	Phase 1	Completed	-	United States, Florida ... 展开 >> Orlando, Florida, United States 收起 <<
NCT01795703	Prostate Cancer	Phase 2	Completed	-	Japan ... 展开 >> Asahi, Japan Fukuoka, Japan Kanazawa, Japan Kita-Gun, Japan Kuki, Japan Kurashiki, Japan Maebashi, Japan Matsuyama, Japan Mitaka, Japan Niigata, Japan Osaka-Sayama, Japan Osaka, Japan Sagamihara, Japan Sakura, Japan Sapporo, Japan Tokyo, Japan Yokohama, Japan Yokosuka, Japan 收起 <<
NCT02887976	Prostate Cancer	Phase 3	Unknown	December 2017	United States, Kansas ... 展开 >> GU Research Network/Wichita Urology Group Wichita, Kansas, United States, 67226 United States, Nebraska GU Research Network/Urology PC Not yet recruiting Lincoln, Nebraska, United States, 68516 Contact: Tony Romero, MS 402-697-2229 tromero@gucancer.com Principal Investigator: Jonathan Henning, MD GU Research Network/Urology Cancer Center Not yet recruiting Omaha, Nebraska, United States, 68130 Contact: Tony Romero, MS 402-697-2229 tromero@gucancer.com Principal Investigator: Luke Nordquist, MD 收起 <<
NCT01424930	Prostate Neoplasms ... 展开 >> Prostate Cancer 收起 <<	Phase 2	Completed	-	Canada, Alberta ... 展开 >> Edmonton, Alberta, Canada Canada, British Columbia Vancouver, British Columbia, Canada 收起 <<
NCT01678573	Healthy	Phase 1	Completed	-	China ... 展开 >> Beijing, China 收起 <<
NCT01717898	-		Terminated(Dose limiting toxic... 展开 >>ities on lowest dose level) 收起 <<	-	-
NCT02787837	-		Recruiting	December 2018	Spain ... 展开 >> Hospital Arquitecto Marcide Recruiting Ferrol, A Coruña, Spain, 15405 Contact: Javier Afonso, MD +34981334000 Franciso.Javier.Afonso.Afonso@sergas.es Hospital Universitario de Santiago Recruiting Santiago de Compostela, A Coruña, Spain, 15706 Contact: Urbano Anido, MD +34981950000 urbanoanido@gmail.com ICO L'Hospitalet Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Contact: Josep M. Piulats, MD +34932607780 jmpiulats@iconcologia.net Hospital Althaia Manresa Recruiting Manresa, Barcelona, Spain, 08243 Contact: Montserrat Domenech, MD +34938759300 ext 3309 mdomenech@althaia.cat Hospital de Especialidades de Jerez de la Frontera Recruiting Jerez de la Frontera, Cádiz, Spain, 11407 Contact: Ruth Viciana, MD +34956032075 ruthvician@gmail.com Hospital Costa del Sol Recruiting Marbella, Málaga, Spain, 29603 Contact: Rosa Villatoro, MD +34951976470 villatororoldan@gmail.com Hospital Universitario de Canarias Recruiting La Laguna, Tenerife, Spain, 38320 Contact: Rosa Delia Garcia, MD +34922678204 rdgmarrero@gmail.com Hospital de Burgos Recruiting Burgos, Spain, 09006 Contact: Guillermo Crespo, MD +34947281978 rescribano@seom.org Contact: Ricardo Sanchez, MD +34947281978 rescribano@seom.org Hospital de Ciudad Real Recruiting Ciudad Real, Spain, 13005 Contact: Jose Carlos Villa, MD +34926278000 ext 77137 jvillaguzman1@yahoo.es Hospital Universitario Reina Sofia Recruiting Cordoba, Spain, 14004 Contact: Maria Jose Mendez, MD +34957011147 mjosemv@yahoo.es Hospital Universitario Virgen de las Nieves Recruiting Granada, Spain, 18014 Contact: Raquel Luque, MD +34958020000 rluquecaro@gmail.com Hospital Universitario de Guadalajara Recruiting Guadalajara, Spain, 19002 Contact: Javier Casinello, MD +34949209200 jacaes@sescam.jccm.es Hospital Universitario Gregorio Maranon Recruiting Madrid, Spain, 28007 Contact: Jose Angel Arranz, MD +34914269070 jarranz@oncomed.gmail.com Coordination PROCURE-Centro Nacional de Investigaciones Oncologicas Recruiting Madrid, Spain, 28029 Contact: Nuria Romero, MD 347328000 ext 2951 nromerol@cnio.es Contact: Berta Nasarre, PhD bnasarre@cnio.es Sub-Investigator: Leticia Rivera, CRA senior Sub-Investigator: Gala Grau, PhD Sub-Investigator: Maria Isabel Pacheco, Technician Sub-Investigator: Teresa Garces, Technician Hospital Universitario Clinico San Carlos Recruiting Madrid, Spain, 28040 Contact: Javier Puente, MD +34913303000 ext 7332 docjavip@yahoo.es Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Daniel Castellanos, MD +34913908339 cdanicas@hotmail.com Centro Integral Oncologico Clara Campal Recruiting Madrid, Spain, 28050 Contact: Elena Castro, MD +34917328000 ext 2950 ecastro@hmhospitales.com Hospital Madrid Sanchinarro Recruiting Madrid, Spain, 28660 Contact: JF Rodríguez Moreno, MD Anatomical Pathology PROCURE-PROSABI Recruiting Malaga, Spain, 29010 Contact: Maria Isabel Pacheco +34951032000 misabel.pacheco.sspa@juntadeandalucia.es Sub-Investigator: Maria Pilar Gonzalez, MD Hospital Regional Universitario Virgen de la Victoria Recruiting Malaga, Spain, 29010 Contact: Maria Isabel Medina, MD +34951291425 msaez.med@gmail.com Hospital Morales Messeguer Recruiting Murcia, Spain, 30008 Contact: Enrique Gonzalez, MD +34968360900 ext 3807 engonbil@um.es Hospital Son Espases Recruiting Palma de Mallorca, Spain, 07120 Contact: Aranzazu Gonzalez, MD +34871206130 ext 76130 aranzazu.gonzalezdealba@ssib.es Complejo Hospitalario de Pontevedra Recruiting Pontevedra, Spain, 36002 Contact: Cristina Azpitarte, MD +34 986800004 crisazpi@hotmail.com Hospital Universitario La Fe Recruiting Valencia, Spain, 46026 Contact: David Lorente, MD +34961244000 davlorente@hotmail.com 收起 <<
NCT01780220	Biochemically-relapsing Prosta... 展开 >>te Adenocarcinoma Following Radical Prostatectomy 收起 <<	Phase 1 Phase 2	Unknown	January 2018	France ... 展开 >> Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Christian CARRIE, Pr Principal Investigator: Christian CARRIE, Pr Institut de Cancérologie de l'ouest/René Gauducheau Recruiting Saint Herblain, Nantes, France, 44805 Contact: Stéphane Supiot, MD, PhD 0240679933 stephane.supiot@ico.unicancer.fr Principal Investigator: stephane Supiot, MD, PhD 收起 <<
NCT01424930	-		Completed	-	-
NCT03360721	Castration-resistant Prostate ... 展开 >>Cancer Metastatic Castration Resistant Prostate Cancer 收起 <<	Phase 2	Recruiting	October 2020	United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact eefstathiou@mdanderson.org 收起 <<
NCT03356444	Prostate Cancer ... 展开 >> Castration-resistant Prostate Cancer Drug 收起 <<	Phase 2	Not yet recruiting	December 2020	-
NCT02883166	Prostate Cancer	Phase 1	Recruiting	March 2018	Netherlands ... 展开 >> Radboud UMC Recruiting Nijmegen, Netherlands, 6500HB Contact: Nielka van Erp, PharmD,PhD 0031243616405 收起 <<
NCT01717898	Castrate-resistant Prostate Ca... 展开 >>ncer 收起 <<	Phase 1 Phase 2	Terminated(Dose limiting toxic... 展开 >>ities on lowest dose level) 收起 <<	-	United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94115 收起 <<
NCT02230046	Healthy	Phase 1	Completed	-	United States, Arizona ... 展开 >> Tempe, Arizona, United States 收起 <<
NCT03732820	Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 3	Recruiting	August 17, 2022	-
NCT02429193	Castration-resistant Prostate ... 展开 >>Cancer 收起 <<	Phase 2	Active, not recruiting	June 2018	Canada, British Columbia ... 展开 >> British Columbia Cancer Agency, Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 收起 <<
NCT01637402	Castration Resistant Prostate ... 展开 >>Cancer 收起 <<	Phase 2	Active, not recruiting	December 2017	United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 79239 收起 <<
NCT01842321	Breast Cancer	Phase 2	Active, not recruiting	July 2020	France ... 展开 >> Ico - Site Paul Papin Angers, France Institut Sainte Catherine Avignon, France Chu - Hopital Jean Minjoz Besancon, France Institut Bergonie Bordeaux, France Polyclinique Bordeaux Nord Aquitaine Bordeaux, France Chu de Brest - Hôpital Morvan Brest, France Centre Francois Baclesse Caen, France Centre Jean Perrin Clermont-ferrand, France Ch Alpes Leman Contamine - Sur - Arve, France Centre Georges-François Leclerc Dijon, France Chu de Grenoble - Hopital Michallon Grenoble, France Clinique Sainte Marguerite Hyeres, France Chd de Vendee La Roche-sur-yon, France Centre Oscar Lambret Lille, France Centre Leon Berard Lyon, France Institut Paoli Calmettes Marseille, France Ch de Mont de Marsan Mont de Marsan, France Centre Antoine Lacassagne Nice, France Chr D Orleans - Hopital La Source Orleans, France Hôpital Saint-Louis Paris, France Hôpital Tenon Paris, France Institut Curie - Hôpital Claudius Regaud Paris, France Ch de Perpignan Perpignan, France Ch Lyon Sud Pierre Benite, France CH de la Région d'Annecy Pringy, France Institut Jean Godinot Reims, France Centre Henri Becquerel Rouen, France Institut Curie - Hôpital René Huguenin Saint-cloud, France Ico- Site Rene Gauducheau Saint-herblain, France Centre Paul Strauss Strasbourg, France Hopital Civil - Strasbourg Strasbourg, France Hopitaux Du Leman Thonon Les Bains, France Institut Claudius Regaud Toulouse, France Ch Bretagne Atlantique Vannes, France Hôpital Privé Océane Vannes, France Gustave Roussy Cancer Campus Villejuif, France 收起 <<
NCT02574910	Congenital Adrenal Hyperplasia	Phase 1	Recruiting	September 2018	United States, California ... 展开 >> Children's Hospital of Los Angeles Not yet recruiting Los Angeles, California, United States, 90027 Contact: Mitchell Geffner, MD mgeffner@chla.usc.edu United States, Maryland National Institutes of Health Not yet recruiting Bethesda, Maryland, United States, 20892-1932 Contact: Deborah Merke, MD 301-496-0718 DMerke@cc.nih.gov United States, Michigan University of Michigan Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Richard Auchus, MD rauchus@med.umich.edu United States, New York North Shore/Long Island Jewish Hospital Not yet recruiting New Hyde Park, New York, United States, 11040 Contact: Phyllis W Speiser, MD 516-472-3750 mailto:PSpeiser@northwell.edu United States, Texas Children's Medical Center Recruiting Dallas, Texas, United States, 75235 Contact: Carolyn Kelly, RN, BS 214-456-2106 carolyn.kelly@childrens.com 收起 <<
NCT02608359	-		Recruiting	August 28, 2020	India ... 展开 >> Healthcare Global (HCG) Hospital Recruiting Bangalore, India, 560027 Tata Memorial Hospital Not yet recruiting Bombay N/A, India, 400012 Rajiv Gandhi Cancer Institute & Research Centre Recruiting Delhi, India, 110085 Christian medical Not yet recruiting Ludhiana, Punjab, India, 141008 P. D. Hinduja National Hospital and Research Center Withdrawn Mumbai, India, 400016 Max Super specialty Recruiting New Delhi, India, 110017 Indraprastha Apollo Hospital Recruiting New Delhi, India, 1100776 收起 <<
NCT02125357	Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 2	Active, not recruiting	July 2019	Canada, British Columbia ... 展开 >> BC Cancer Agency - Abbotsford Abbotsford, British Columbia, Canada, V2S 0C2 BC Cancer Agency - Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BC Cancer Agency - Centre for the North Prince George, British Columbia, Canada, V2N 7E9 BC Cancer Agency - Fraser Valley Surrey, British Columbia, Canada, V3V 1Z2 Vancouver Prostate Centre Vancouver, British Columbia, Canada, V5Z 1M9 BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency - Vancouver Island Victoria, British Columbia, Canada, V8R 6V5 收起 <<
NCT01199146	Prostate Cancer	Phase 2	Completed	-	United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94115 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 收起 <<
NCT01940276	Prostate Cancer	Phase 2	Active, not recruiting	October 2019	United States, Alabama ... 展开 >> Birmingham VA Medical Center Birmingham, Alabama, United States, 35233 United States, Louisiana Tulane Cancer Center New Orleans, Louisiana, United States, 70112 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 Duke University Medical Center Durham, North Carolina, United States, 27710 Maria Parham Medical Center Henderson, North Carolina, United States, 27536 Scotland Memorial Hospital Laurinburg, North Carolina, United States, 28352 Southeastern Regional Lumberton, North Carolina, United States, 28359 Duke Raleigh Hospital Raleigh, North Carolina, United States, 27609 W. G. 'Bill' Hefner VA Medical Center Salisbury, North Carolina, United States, 28144 Johnston Memorial Hospital Smithfield, North Carolina, United States, 27577 Wake Forest University Winston-Salem, North Carolina, United States, 27157 United States, South Carolina Spartanburg Regional Spartanburg, South Carolina, United States, 29303 United States, Virginia Virginia Oncology Associates Hampton, Virginia, United States, 23666 收起 <<
NCT03173859	Prostatic Neoplasms, Castratio... 展开 >>n-Resistant 收起 <<	Phase 2	Not yet recruiting	December 1, 2021	-
NCT01495910	21-hydroxylase Deficiency	Phase 1	Completed	-	United States, Illinois ... 展开 >> Chicago, Illinois, United States United States, Michigan Ann Arbor, Michigan, United States United States, Texas Dallas, Texas, United States 收起 <<
NCT01655147	Healthy	Phase 1	Completed	-	Belgium ... 展开 >> Merksem, Belgium 收起 <<
NCT03145285	Cushing Syndrome ... 展开 >> Adrenocortical Carcinoma 收起 <<	Phase 2	Active, not recruiting	April 18, 2021	Italy ... 展开 >> U.O Oncologia Medica Brescia, BS, Italy, 25123 收起 <<
NCT01735396	-		Terminated(poor accrual)	-	-
NCT02656615	Prostate Cancer	Phase 2	Terminated(Lack of Patient acc... 展开 >>rual) 收起 <<	-	Switzerland ... 展开 >> Cantonal Hospital Chur Chur, Graubuenden, Switzerland, 7000 University Hospital Basel Basel, Switzerland, 4000 Cantonal Hospital St.Gallen St.Gallen, Switzerland, 9007 收起 <<
NCT02867852	Salivary Glands Tumors	Phase 2	Unknown	December 2017	Italy ... 展开 >> Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Lombardy, Italy, 20133 Contact: Laura Locati, MD +39 022390 ext 2805 laura.locati@istitutotumori.mi.it Contact: Roberta Granata, MD +39 022390 ext 2765 roberta.granata@istitutotumori.mi.it 收起 <<
NCT02426333	-		Recruiting	March 2018	Netherlands ... 展开 >> Jeroen Bosch Ziekenhuis Not yet recruiting Den Bosch, Netherlands Sub-Investigator: Tineke Smilde, MD, PhD Canisius Wilhelmina Ziekenhuis Recruiting Nijmegen, Netherlands Contact: Rik Somford, MD,PhD Sub-Investigator: Rik Somford, MD, PhD Radboud UMC Recruiting Nijmegen, Netherlands Contact: Nielka van Erp, PharmD, PhD Principal Investigator: Nielka van Erp, PharmD, PhD Principal Investigator: Jack Schalken, PhD 收起 <<
NCT01961843	Prostate Cancer	Not Applicable	Active, not recruiting	October 2018	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT03565835	Prostatic Neoplasms	Phase 2	Recruiting	January 2022	United States, New York ... 展开 >> Montefiore Medical Center Recruiting Bronx, New York, United States, 10461 Contact: Benjamin Gartrell, MD 718-405-8404 bgartrel@montefiore.org 收起 <<
NCT01735396	Prostate Cancer	Phase 2	Terminated(poor accrual)	-	United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Queens Cancer Center, Queens Hospital New York, New York, United States, 11432 收起 <<
NCT02415621	Prostate Cancer	Not Applicable	Recruiting	December 2020	United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Jesse Mocha 813-745-2629 jesse.mocha@moffitt.org Contact: Jingsong Zhang, M.D., Ph.D. 813-745-1363 jingsong.zhang@moffitt.org Principal Investigator: Jingsong Zhang, M.D., Ph.D. Sub-Investigator: Mayer Fishman, M.D., Ph.D. Sub-Investigator: Julie Kish, M.D. 收起 <<
NCT01199146	-		Completed	-	-
NCT02911467	Prostate Cancer	Phase 1	Recruiting	December 30, 2020	United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94158 Contact: Rahul Aggarwal, MD 415-353-9278 Rahul.Aggarwal@ucsf.edu Contact: Paula Dutton, BS 415-885-7871 Paula.Dutton@ucsf.edu 收起 <<
NCT02920229	68Ga-PSMA HBED-PET/CT ... 展开 >> Prostate Cancer 收起 <<	Not Applicable	Recruiting	November 2018	Italy ... 展开 >> Irst Irccs Recruiting Meldola, FC, Italy, 47014 Contact: Federica Matteucci, MD +390543739100 federica.matteucci@irst.emr.it Principal Investigator: Federica Matteucci, MD Sub-Investigator: Ugo De Giorgi, MD 收起 <<
NCT03170960	Urothelial Carcinoma ... 展开 >> Renal Cell Carcinoma Non-Small Cell Lung Cancer Castration-resistant Prostate Cancer Triple Negative Breast Cancer Ovarian Cancer Endometrial Cancer Hepatocellular Carcinoma Gastric Cancer Gastroesophageal Junction Adenocarcinoma Colorectal Cancer Head and Neck Cancer Differentiated Thyroid Cancer 收起 <<	Phase 1 Phase 2	Recruiting	December 2020	-
NCT02398526	-		Active, not recruiting	September 30, 2023	Germany ... 展开 >> Multiple Locations, Germany 收起 <<
NCT02312557	Castration-Resistant Prostate ... 展开 >>Carcinoma Hormone-Resistant Prostate Cancer PSA Progression Recurrent Prostate Carcinoma Stage IV Prostate Adenocarcinoma AJCC v7 收起 <<	Phase 2	Active, not recruiting	-	United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 收起 <<
NCT01162395	Prostate Cancer	Phase 1	Completed	-	United States, Oregon ... 展开 >> Research Site Portland, Oregon, United States Netherlands Research Site Amsterdam, Netherlands United Kingdom Research Site Glasgow, United Kingdom Research Site Manchester, United Kingdom Research Site Surrey, United Kingdom 收起 <<
NCT02711137	Solid Tumors	Phase 1 Phase 2	Active, not recruiting	December 2018	United States, Alabama ... 展开 >> University of Alabama Birmingham, Alabama, United States, 35294-3300 United States, California University of California La Jolla, California, United States, 92093 United States, Colorado Sarah Cannon Research Institute at Health One Denver, Colorado, United States, 80218 United States, Connecticut Yale University New Haven, Connecticut, United States, 06510 United States, Florida Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Hematology - Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States, 34952 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, New York University of Rochester, Wilmot Cancer Center Rochester, New York, United States, 14642 United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 United States, Texas Oncology Consultants, P.A. Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Washington MultiCare Institute for Research and Innovation Tacoma, Washington, United States, 98405 Belgium Institut Jules Bordet, Clinical Trial Conduct Unit Brussels, Belgium, B-1000 France HÔPITAL SAINT-LOUIS, Service Hématologie Adultes Paris, France, 75010 收起 <<
NCT03437941	Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 1 Phase 2	Recruiting	July 31, 2021	United States, Arizona ... 展开 >> Honor Health Recruiting Scottsdale, Arizona, United States, 85258 Contact: Michael Gordon, MD 623-238-7630 United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Michael Morris, MD 646-422-4469 United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Tomasz Beer, MD 503-494-1080 United Kingdom University College Hospital London Recruiting London, England, United Kingdom, NW1 Contact: Mark Linch, MD, PhD 020 3447 9287 University of Southampton Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Simon Crabb, MD, PhD 023 8120 5170 Royal Marsden NHS Foundation Trust Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Johann De Bono, MD, PhD 0800 180 81 82 收起 <<
NCT02813226	Prostate Cancer	Not Applicable	Active, not recruiting	December 2020	Canada, Ontario ... 展开 >> Juravinski Hospital and Cancer Centre Hamilton, Ontario, Canada London Health Sciences Centre London, Ontario, Canada Sunnybrook-Odette Cancer Centre Toronto, Ontario, Canada 收起 <<
NCT02788201	Urothelial Carcinoma ... 展开 >> Bladder Cancer Urinary Bladder Neoplasms 收起 <<	Phase 2	Recruiting	July 1, 2020	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 <<
NCT03678025	Castration Levels of Testoster... 展开 >>one Metastatic Prostatic Adenocarcinoma Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 收起 <<	Phase 3	Recruiting	October 1, 2031	United States, Texas ... 展开 >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Brian Chapin, MD 收起 <<
NCT03551782	Castration-Resistant Prostatic... 展开 >> Neoplasms 收起 <<	Phase 1	Recruiting	January 29, 2021	-
NCT01331083	Prostate Cancer	Phase 2	Completed	-	Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 收起 <<
NCT02008058	-		Active, not recruiting	December 2021	United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington University of Washington Seattle, Washington, United States, 98109 收起 <<
NCT02729103	-		Completed	-	United States, New Jersey ... 展开 >> Whippany, New Jersey, United States 收起 <<
NCT03075735	-		Active, not recruiting	December 15, 2018	-
NCT02091531	Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 2	Completed	-	United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 <<
NCT01771458	Reccurent/Metastatic Solid Tum... 展开 >>or Disease 收起 <<	Phase 2	Unknown	December 2016	France ... 展开 >> Centre régional de lutte contre le cancer de Bourgogne Georges François Leclerc Dijon, France, 21079 Centre Leon Berard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Insitut Curie Paris, France, 75248 Institut Curie Hopital Rene Huguenin Saint-cloud, France, 92210 Institut de cancérologie de l'Ouest Centre René Gauducheau Saint-herblain, France, 44000 Institut Claudius Régaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre Les Nancy, France, 54500 收起 <<
NCT03690141	Castrate-resistant Prostate Ca... 展开 >>ncer (CRPC) 收起 <<	Phase 2	Recruiting	April 2022	United States, Connecticut ... 展开 >> Yale Cancer Center Not yet recruiting New Haven, Connecticut, United States, 06510 Principal Investigator: Daniel Petrylak, M.D. United States, Illinois Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Lela Lartey 312-695-1377 emanuela.lartey@northwestern.edu Principal Investigator: Maha Hussain, M.D. United States, Maryland Kimmel Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Contact: Rehab Abdallah 443-253-7021 rabdall1@jhmi.edu Principal Investigator: Michael Carducci, M.D. United States, Michigan Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 Principal Investigator: Elisabeth Heath, M.D. United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Andrew Atkocius 314-747-1343 a.atkocius@wustl.edu Principal Investigator: Joel Picus, M.D. United States, Nevada Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 Principal Investigator: Nicholas Vogelzang, M.D. United States, Ohio The Urology Group Recruiting Cincinnati, Ohio, United States, 45212 Contact: Bill Corbett 513-841-7555 wcorbett@urologygroup.com Principal Investigator: Marc Pliskin, M.D. United States, Pennsylvania Lancaster Urology Recruiting Lancaster, Pennsylvania, United States, 17604 Contact: Dawn Stern 717-431-2285 Dawns@lancuro.com Principal Investigator: Paul Sieber, M.D. United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 Contact: Laura Prince 843-839-1679 lprince@curcmb.com Principal Investigator: Neal Shore, M.D. United States, Washington University of Washington Not yet recruiting Seattle, Washington, United States, 89109 Principal Investigator: Celestia Higano, M.D. 收起 <<
NCT02711956	Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 1 Phase 2	Recruiting	June 2019	United States, California ... 展开 >> University of California Los Angeles Medical Center Recruiting Los Angeles, California, United States University of California San Francisco Medical Center Recruiting San Francisco, California, United States United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States Karmanos Cancer Institute Recruiting Farmington Hills, Michigan, United States United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Weill Cornell Medicine - New York Presbyterian Recruiting New York, New York, United States United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States 收起 <<
NCT02288936	Hormone-refractory Prostate Ca... 展开 >>ncer 收起 <<	Phase 2	Active, not recruiting	January 2019	Spain ... 展开 >> Hospital Universitari Germans Trias I Pujol de Badalona Badalona, Barcelona, Spain, 08916 Hospital Universitari Son Espases Palma de Mallorca, Islas Baleares, Spain, 07120 Hospital Clinic I Provincial de Barcelona Barcelona, Spain, 08036 Hospital Parc Taulí Barcelona, Spain Complejo Hospitalario Regional Reina Sofía Córdoba, Spain, 14004 Complejo Asistencial Universitario de Leon León, Spain, 24080 Hospital Universitario Lucus Augusti Lugo, Spain, 27003 Hospital Ramón Y Cajal Madrid, Spain, 28034 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital General Universitario J.M. Morales Meseguer Murcia, Spain, 30008 Complejo Hospitalario de Especialidades Virgen de La Victoria Málaga, Spain, 29010 Complexo Hospitalario Universitario de Ourense Ourense, Spain, 32005 Complejo Hospitalario Regional Virgen Del Rocio Sevilla, Spain, 41013 Fundación Instituto Valenciano de Oncologia Valencia, Spain, 46009 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 收起 <<
NCT03356912	Prostate Cancer ... 展开 >> Castration-resistant Prostate Cancer 收起 <<	Phase 2	Enrolling by invitation	May 4, 2021	Italy ... 展开 >> University Federico II of Naples Naples, Italy 收起 <<
NCT02522715	Castration Levels of Testoster... 展开 >>one Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer AJCC v7 收起 <<	Phase 1 Phase 2	Recruiting	August 31, 2025	United States, Oregon ... 展开 >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Julie N. Graff 503-220-8262 ext 55688 graffj@ohsu.edu Principal Investigator: Julie N. Graff Portland Veterans Administration Medical Center Recruiting Portland, Oregon, United States, 97239 Contact: Julie N. Graff 503-220-8262 ext 55688 graffj@ohsu.edu Principal Investigator: Julie N. Graff United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Heather H. Cheng 800-804-8824 hhcheng@u.washington.edu Principal Investigator: Heather H. Cheng 收起 <<
NCT03763253	Prostate Cancer ... 展开 >> Metastatic Prostate Cancer 收起 <<	Phase 2	Not yet recruiting	March 1, 2024	United Kingdom ... 展开 >> Wirral University Teaching Hospital Not yet recruiting Birkenhead, United Kingdom, CH49 5PE Contact: Manal Kumar, MBBS MS MSh FRCS ED Principal Investigator: Manal Kumar, MBBS MS MSh FRCS ED Broomfield Hospital Not yet recruiting Chelmsford, United Kingdom, CM1 7ET Contact: Casey Rowan, FRCS (Urol) Principal Investigator: Casey Rowan, FRCS (Urol) Ashford and St Peters Not yet recruiting Chertsey, United Kingdom, KT16 0PZ Contact: Nimalan Arumainayagam, FRCS (Urol) Principal Investigator: Nimalan Arumainayagam, FRCS (Urol) Royal Devon and Exeter NHS Trust Not yet recruiting Exeter, United Kingdom, EX2 5DW Contact: John McGrath, BMedSci BMBS FRCS Principal Investigator: John McGrath, BMedSci BMBS FRCS Wycombe General Hospital Not yet recruiting High Wycombe, United Kingdom, HP11 2TT Contact: Neil Haldel, MBBS MB FRCS (Urol) Principal Investigator: Neil Haldel, MBBS MB FRCS (Urol) West Middlesex University Hospital Not yet recruiting Isleworth, United Kingdom, TW7 6AF Contact: Mathias Winkler, MBBS BSc MD FRCS (Urol) Principal Investigator: Mathias Winkler, MBBS BSc MD FRCS (Urol Cambridge Queen Elizabeth hospital, Kings Lynn Not yet recruiting King's Lynn, United Kingdom, PE30 4ET Contact: Gail Horan, MRCPI, FRCR Principal Investigator: Gail Horan, MRCPI, FRCR Guys and St Thomas Hospital Not yet recruiting London, United Kingdom, SE1 7EH Contact: Paul Cathcart, FRCS (Urol) Principal Investigator: Paul Cathcart, FRCS (Urol) St George's Hospital, St. George's University Hospitals NHS Foundation Trust Not yet recruiting London, United Kingdom, SW17 0QT Contact: Hasan Qazi, FRCS (Urol) Principal Investigator: Hasan Qazi, FRCS (Urol) Imperial College Healthcare NHS Trust Not yet recruiting London, United Kingdom, W6 8RF Contact: Hashim U Ahmed, BM, BCh (Oxon), BA, PhD, FRCS Principal Investigator: Hashim U Ahmed, BM, BCh (Oxon), BA, PhD, FRCS Sub-Investigator: Taimur T Shah, MBBS, BSc (Hons), MRCS Sub-Investigator: Martin J Connor, MBBS, BSc (Hons), MSc, MRCS Sub-Investigator: Mathias Winkler, MD, FRCS (Urol) Sub-Investigator: John Staffurth, MD, FRCP, FRCR Sub-Investigator: Alison Falconer, MA, MRCP, FRCR Sub-Investigator: Suraiya Dubash, MBBS, BSc, MRCP, FRCR London North West University Healthcare (Northwick Park) Not yet recruiting London, United Kingdom Contact: Giles Hellawell, MA BM BCH FRCS Principal Investigator: Giles Hellawell, MA BM BCH FRCS Newcastle Hospitals NHS trust (Freeman Hospital) Not yet recruiting Newcastle, United Kingdom, NE7 7DM Contact: Rakesh Heer, PhD FRCS(Urol) Principal Investigator: Rakesh Heer, PhD FRCS(Urol) Glan Clwyd Hospital (Betsi Cadwaladr University Health Board) Not yet recruiting Rhyl, United Kingdom, LL18 5UJ Contact: Kingsley Ekwueme, FRCS (Urol) Principal Investigator: Kingsley Ekwueme, FRCS (Urol) Southampton General Hospital Not yet recruiting Southampton, United Kingdom, SO16 6YD Contact: Tim Dudderidge, FRCS (Urol) Principal Investigator: Tim Dudderidge, FRCS (Urol) Lister Hospital Not yet recruiting Stevenage, United Kingdom, SG1 4AB Contact: Nikhil Vasdev, FRCS (Urol) Principal Investigator: Nikhil Vasdev, FRCS (Urol) Sunderland Royal hospital Not yet recruiting Sunderland, United Kingdom, SR4 7TP Contact: Stuart McCracken, FRCS (Urol) Principal Investigator: Stuart McCraken, FRCS (Urol) Wrexham Maelor Hospital (Betsi Cadwaladr University Health Board) Not yet recruiting Wrexham, United Kingdom, LL13 7TD Contact: Iqbal Shergill, FRCS (Urol) Principal Investigator: Iqbal Shergill, FRCS (Urol) 收起 <<
NCT02494921	Prostate Cancer	Phase 1 Phase 2	Recruiting	December 2019	United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center Active, not recruiting San Francisco, California, United States, 94115 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Benedito A. Carneiro, MD 312-472-1234 Principal Investigator: Benedito A. Carneiro, MD United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: David Smith, MD 800-865-1125 Principal Investigator: David Smith, MD 收起 <<
NCT02432001	-		Recruiting	December 2018	United States, California ... 展开 >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Primo Lara, MD University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Matthew Rettig, MD UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Paula Dutton 415-885-7871 Paula.Dutton@ucsf.edu United States, Oregon Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Tomasz Beer, MD Canada University of British Columbia Recruiting Vancouver, Canada Contact: Kim Chi, MD 收起 <<
NCT02202447	Prostate Cancer	Phase 1	Active, not recruiting	October 2018	United States, Arizona ... 展开 >> Scottsdale Healthcare Clinical Trials at the Virginia G. Piper Cancer Center Scottsdale, Arizona, United States, 85258 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Louisiana Tulane Cancer Center New Orleans, Louisiana, United States, 70112 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10017 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 收起 <<
NCT02606123	Prostatic Neoplasms ... 展开 >> Genital Neoplasms, Male Genital Diseases, Male Prostatic Diseases 收起 <<	Phase 1 Phase 2	Terminated(At end of Phase 1 e... 展开 >>xcessive high pill burden (18 capsules/day)) 收起 <<	-	United States, Arizona ... 展开 >> Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States, 85258 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, British Columbia British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 收起 <<
NCT03526562	Prostatic Neoplasms ... 展开 >> Exercise Castration-resistant Prostate Cancer Physical Activity 收起 <<	Not Applicable	Recruiting	October 2018	Belgium ... 展开 >> University Hospital ghent Recruiting Ghent, Oost-Vlaanderen, Belgium, 9000 Contact: Renée Bultijnck, Msc 932 3320342 renee.bultijnck@ugent.be Contact: Piet Ost, MD, PhD 收起 <<
NCT03655886	Prostate Cancer Metastatic	Phase 2	Recruiting	August 1, 2022	Belgium ... 展开 >> University Hospital Ghent Recruiting Ghent, Belgium Contact: Nicolaas Lumen, PhD +3293322276 poli.urologie@uzgent.be 收起 <<
NCT01647789	Prostatic Neoplasms	Phase 1	Terminated	-	United States, California ... 展开 >> UCSF Medical Center Dept of Oncology San Francisco, California, United States, 94143 United States, Texas Cancer Therapy & Research Center UT Health Science Center InstituteForDrugDevelopment(2) San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Dept. of SCCA Seattle, Washington, United States, 98105 United States, Wisconsin University of Wisconsin Univ Wisc Madison, Wisconsin, United States, 53792 Belgium Novartis Investigative Site Bouge, Belgium, 5004 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 收起 <<
NCT02621190	Prostatic Neoplasms	Phase 2	Withdrawn(no approval)	June 2019	Netherlands ... 展开 >> Erasmus MC Cancer Institute Rotterdam, Netherlands, 3075 EA 收起 <<
NCT01487720	Prostate Cancer	Phase 2	Completed	-	Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 <<
NCT03050866	Circulating Tumor Cell ... 展开 >> Metastatic Prostate Cancer 收起 <<	Phase 2	Recruiting	February 2020	Netherlands ... 展开 >> Reinier de Graaf Groep Recruiting Delft, Netherlands Contact: A.C.M. Van de Luijtgaarden, MD Principal Investigator: A.C.M. Van de Luijtgaarden, MD Medisch Centrum Haaglanden Recruiting Den Haag, Netherlands Contact: H. Helgason, MD Principal Investigator: H Helgason, MD Groene Hart Ziekenhuis Recruiting Gouda, Netherlands Contact: W. Van der Deure, MD Principal Investigator: W Van der Deure, MD Canisius Wilhelmina Ziekenhuis Recruiting Nijmegen, Netherlands Contact: R. Somford, MD Principal Investigator: R. Somford, MD Erasmus MC Recruiting Rotterdam, Netherlands Contact: Bodine Belderbos caba.v7@erasmusmc.nl Franciscus Gasthuis en Vlietland Recruiting Rotterdam, Netherlands Contact: Paul Hamberg Maasstad Ziekenhuis Recruiting Rotterdam, Netherlands Contact: B. Haberkorn, MD Principal Investigator: B. Haberkorn, MD Tweesteden Ziekenhuid Recruiting Tilburg, Netherlands Contact: A. Coumou, MD Principal Investigator: A Coumou, MD Admiraal de Ruyter Ziekenhuis Recruiting Vlissingen, Netherlands Contact: H.K. Van Halteren, MD Principal Investigator: H.K. Van Halteren, MD 收起 <<
NCT02826772	Metastatic Castrate Resistant ... 展开 >>Prostate Cancer (mCRPC) 收起 <<	Phase 1 Phase 2	Recruiting	December 2018	United States, Maryland ... 展开 >> Chesapeake Urology Research Associates Recruiting Towson, Maryland, United States, 21204 Contact: Heather Thomas, CCRC 443-471-5742 hthomas@cua.md Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Richard Levin, MD United States, Nebraska G U Research Network Recruiting Omaha, Nebraska, United States, 68130 Contact: Tony Romero, MS, CCRC 402-697-2229 tromero@gucancer.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Luke T Nordquist, MD United States, Nevada Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 Contact: Khin Win, MBA, MBBS 702-952-3834 khin.win@usoncology.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Nicholas Vogelzang, MD United States, New Jersey Rutgers University Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Tracie Saunders, RN, MS, OCN, CCRC 732-235-8861 tracie.saunders@cinj.rutgers.edu Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Mark N Stein, MD United States, New York North Shore Hematology Oncology Associates Recruiting East Setauket, New York, United States, 11733 Contact: Don Marx, MBA, MS, RT 631-675-5143 dmarx@nycancer.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Jeffrey L Vacirca, MD, FACP United States, Ohio Gabrail Cancer Center Research Recruiting Canton, Ohio, United States, 44718 Contact: Carrie Smith, RN 484-998-8315 csmith@gabrailcancercenter.com Contact: Heidi Miller, BScN 514.463.8837 hmiller@accelovance.com Principal Investigator: Nashat Gabrail, MD 收起 <<
NCT03016312	Prostatic Neoplasms, Castratio... 展开 >>n-Resistant 收起 <<	Phase 3	Active, not recruiting	July 9, 2022	-
NCT01513733	Prostate Cancer	Phase 1	Completed	-	United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 United States, North Carolina Duke Cancer Institute Durham, North Carolina, United States, 27710 收起 <<
NCT02012920	Castration-resistant Prostate ... 展开 >>Cancer CRPC 收起 <<	Phase 2	Active, not recruiting	December 2018	-
NCT02269982	-		Active, not recruiting	November 30, 2018	United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 收起 <<
NCT02856100	-		Unknown	December 2018	United States, Maryland ... 展开 >> Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Ghedem Solomon, MS 410-614-2789 gsolomo6@jhmi.edu Contact: Akimosa Jeffrey-Kwanisai, MBA 410-502-1040 ajeffre2@jhmi.edu 收起 <<
NCT00268476	Prostate Cancer	Phase 2 Phase 3	Recruiting	September 2024	-
NCT02907372	Metastatic Castration-resistan... 展开 >>t Prostate Cancer (CRPCa) 收起 <<	Not Applicable	Recruiting	November 2020	France ... 展开 >> CHU Recruiting Amiens, France Contact: Mathieu BOONE, MD Principal Investigator: Mathieu BOONE centre François Baclesse Recruiting Caen, France Contact: Florence JOLY, PhD Principal Investigator: Florence JOLY, PhD Institut régional du Cancer de Montpellier (ICM) Recruiting Montpellier, France Contact: Amélie DARLIX, MD Principal Investigator: Amélie DARLIX, MD Chu Rouen Recruiting Rouen, France Contact: Sophie GOUERANT, MD Principal Investigator: Sophie GOUERANT, MD CHU Not yet recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD Principal Investigator: Philippe BARTHELEMY, MD IGR Not yet recruiting Villejuif, France Contact: Giulia BACIARELLO, PhD Principal Investigator: Karim FIZAZI, PhD 收起 <<
NCT01171898	Prostate Cancer	Phase 1 Phase 2	Active, not recruiting	December 31, 2018	United States, California ... 展开 >> San Diego, California, United States San Francisco, California, United States United States, Georgia Atlanta, Georgia, United States United States, Maryland Baltimore, Maryland, United States United States, Massachusetts Boston, Massachusetts, United States United States, Michigan Ann Arbor, Michigan, United States United States, Nebraska Omaha, Nebraska, United States United States, New York New York, New York, United States United States, North Carolina Raleigh, North Carolina, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Lancaster, Pennsylvania, United States United States, South Carolina Myrtle Beach, South Carolina, United States United States, Texas Dallas, Texas, United States United States, Washington Seattle, Washington, United States United States, Wisconsin Madison, Wisconsin, United States 收起 <<
NCT03514836	Castration-resistant Prostate ... 展开 >>Cancer 收起 <<	Phase 1 Phase 2	Recruiting	April 2021	Czechia ... 展开 >> Fakultní nemocnice v Motole Recruiting Praha, Czechia, 150 06 收起 <<
NCT01695044	Prostate Cancer	Phase 2	Completed	-	-
NCT01695044	-		Completed	-	-
NCT02525068	Adenocarcinoma of the Prostate	Phase 2	Recruiting	March 2020	United Kingdom ... 展开 >> Royal Marsden Hospital Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Principal Investigator: Johann De Bono, Professor 收起 <<
NCT03236688	-		Recruiting	September 2018	United States, Connecticut ... 展开 >> Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Ken F Blount, Ph.D. 203-785-5927 ken.blount@yale.edu Principal Investigator: Daniel Petrylak, MD 收起 <<
NCT03696186	Castration-resistant Prostate ... 展开 >>Cancer Prostate Cancer Metastatic 收起 <<	Phase 2	Recruiting	August 2023	China ... 展开 >> Tianjin Medical Unversity Second Hospital Recruiting Tianjin, China, 300211 Contact: Rong Han +86 022 8832 8677 miyansuo@126.com Principal Investigator: Yuanjie Niu, MD,PhD Sub-Investigator: Shimiao Zhu, MD,PhD 收起 <<
NCT02456571	-		Recruiting	June 2019	United States, North Carolina ... 展开 >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Monika Anand, PhD 919-681-8838 monika.anand@duke.edu 收起 <<
NCT03725761	Prostate Cancer	Phase 2	Recruiting	June 1, 2021	United States, California ... 展开 >> UCSD Moores Cancer Center Not yet recruiting La Jolla, California, United States, 92093 Contact: Candance Winkler 858-822-5398 cmwinkler@ucsd.edu Principal Investigator: Rana McKay, MD United States, Michigan Wayne State University Barbara Ann Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 Contact: Brenda Dickow 313-576-9372 dickowb@karmanos.org Principal Investigator: Elisabeth Heath, MD United States, Minnesota University of Minnesota Masonic Cancer Center Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Shilpa Gupta 612-625-0571 guptash@umn.edu Principal Investigator: Arpit Rao, MD United States, New York Memorial Sloan-Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Rebecca Green 646-888-1313 borsukr@mskcc.org Principal Investigator: Susan Slovin, MD Weill Cornell Medical College Not yet recruiting New York, New York, United States, 10065 Contact: Jyoti Sreekumar 646-962-9340 jys2004@med.cornell.edu Principal Investigator: Himisha Beltran, MD United States, Wisconsin University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Mary Jane Staab 608-263-7107 mjs@medicine.wisc.edu Principal Investigator: Christos Kyriakopoulos 收起 <<
NCT03581500	Prostate Adenocarcinoma ... 展开 >> PSA Level Greater Than Ten Stage IIB Prostate Cancer AJCC v8 Stage III Prostate Cancer AJCC v8 Stage IIIA Prostate Cancer AJCC v8 Stage IIIB Prostate Cancer AJCC v8 Stage IIIC Prostate Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 收起 <<	Phase 2	Not yet recruiting	August 31, 2019	United States, Texas ... 展开 >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact vkundra@mdanderson.org 收起 <<
NCT02853097	-		Recruiting	June 14, 2021	United States, California ... 展开 >> Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Cheryl Kefauve, RN 323-865-0459 Cheryl.Kefauver@med.usc.edu Principal Investigator: Jacek Pinski, MD USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Cheryl Kefauver, RN 323-865-0459 Cheryl.Kefauver@med.usc.edu Principal Investigator: Jacek Pinski, MD Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Cheryl Kefauver, RN 323-865-0459 Cheryl.Kefauver@med.usc.edu Principal Investigator: Jacek Pinski, MD 收起 <<
NCT02512185	-		Recruiting	February 2019	Canada, Ontario ... 展开 >> Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Sebastien Hotte, MD 905-387- 9711 ext 64605 sebastien.hotte@jcc.hhsc.ca Kingston Health Sciences Centre -KGH Recruiting Kingston, Ontario, Canada, K7L 2V7 Contact: Carrie Lindsay : 613-549-6666 ext 7231 Carrie.Lindsay@kingstonhsc.ca Principal Investigator: Richard Gregg, MD., FRCPC Odette Cancer Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Urban Emmenegger, MD 416-480-4928 urban.emmenegger@sunnybrook.ca Sub-Investigator: Scott Berry, MD Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Henriette Breunis +1-416-946-4501 ext 3926 hbreunis@uhnresearch.ca Principal Investigator: Shabbir Alibhai, MD Sub-Investigator: Anthony Joshua, MD Sub-Investigator: Aaron Hansen, MD 收起 <<
NCT02286921	Castration Resistant Metastati... 展开 >>c Prostate Cancer 收起 <<	Phase 2	Active, not recruiting	December 2019	United States, District of Col... 展开 >>umbia Sibley Memorial Hospital Washington, District of Columbia, United States, 20016 United States, Maryland SKCCC at Johns Hopkins Baltimore, Maryland, United States, 21205 收起 <<
NCT01171898	-		Active, not recruiting	-	-
NCT02607228	Metastatic Castrate-Resistant ... 展开 >>Prostate Cancer 收起 <<	Phase 1 Phase 2	Active, not recruiting	December 2018	United States, California ... 展开 >> San Francisco, California, United States, 94158 United States, Maryland Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, North Carolina Durham, North Carolina, United States, 27710 收起 <<
NCT03043807	Prostate Cancer	Phase 2	Recruiting	February 2022	United States, Maryland ... 展开 >> Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21205 The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Rana Sullivan 410-614-6337 tomalra@jhmi.edu Contact: Donna Dowling 410-614-9526 ddowlin1@jhmi.edu Principal Investigator: Kenneth Pienta, MD 收起 <<
NCT02121600	Prostate Cancer	Not Applicable	Active, not recruiting	June 2019	Canada, Ontario ... 展开 >> Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 收起 <<
NCT03007732	Prostatic Neoplasms	Phase 2	Recruiting	April 2022	United States, California ... 展开 >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Clinical Trials Office - UCSF Helen Diller Family Comprehensi 877-827-3222 University of California San Francisco Recruiting San Francisco, California, United States, 94115 Contact: Julie McCluggage, RN 415-514-8133 Julie.McCluggage@ucsf.edu Contact: Lissa Gray, NP 415-514-8133 Lissa.Gray@ucsf.edu Principal Investigator: Lawrence Fong, MD 收起 <<
NCT03556904	Prostate Cancer	Phase 2	Recruiting	September 1, 2023	United States, Michigan ... 展开 >> University of Michigan Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Zachery Reichert, MD, PhD 734-764-3066 zreiche@med.umich.edu 收起 <<
NCT02903160	Prostate Cancer	Phase 2	Recruiting	October 2019	United States, New York ... 展开 >> Mount Sinai Beth Israel Recruiting New York, New York, United States, 10011 Contact: Bobby Liaw, MD 212-604-6010 bobby.liaw@mountsinai.org Principal Investigator: Bobby Liaw, MD Mount Sinai West Withdrawn New York, New York, United States, 10019 Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10028 Contact: William Oh, MD 212-659-5549 william.oh@mssm.edu Principal Investigator: William Oh, MD 收起 <<
NCT03554317	Castration-resistant Prostate ... 展开 >>Cancer Metastatic Prostate Cancer Prostate Cancer 收起 <<	Phase 2	Recruiting	July 2021	United States, Maryland ... 展开 >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Michaella Afful, RN 410-502-0017 mafful1@jhmi.edu Contact: Rana Sullivan, RN 410-614-6337 tomalra@jhmi.edu Principal Investigator: Mark Markowski, MD, Ph.D 收起 <<
NCT03419442	-		Not yet recruiting	February 28, 2019	United States, New Jersey ... 展开 >> US database Not yet recruiting Whippany, New Jersey, United States, 07981 收起 <<
NCT01953640	-		Active, not recruiting	December 2018	United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT02861573	Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 <<	Phase 1	Recruiting	May 18, 2022	United States, California ... 展开 >> Call for Information (Investigational Site 0007) Recruiting Irvine, California, United States, 92697 Call for Information (Investigational Site 0005) Recruiting Los Angeles, California, United States, 90095 Call for Information (Investigational Site 0001) Recruiting San Francisco, California, United States, 94115 United States, New Jersey Call for Information (Investigational Site 0015) Recruiting New Brunswick, New Jersey, United States, 08903 United States, Washington Call for Information (Investigational Site 0016) Recruiting Seattle, Washington, United States, 98109 Canada, Quebec Merck Canada Recruiting Kirkland, Quebec, Canada, H9H 4M7 Contact: Medical Information Centre Centre d'information medicale Merck Canada Inc. 514-428-8600 / 1-800-567-2594 New Zealand Merck Sharp & Dohme (New Zealand) Ltd., Recruiting Wellington, New Zealand Contact: Australian Medical Information Centre 61 2 8988 8428 收起 <<
NCT03432949	Metastatic Prostate Cancer	Phase 4	Recruiting	February 15, 2021	Canada, Ontario ... 展开 >> University Health Network Recruiting Toronto, Ontario, Canada Contact: Michele Petrovic 416-946-4501 ext 5259 michele.petrovic@uhn.ca Principal Investigator: Neil Fleshner, MD Sub-Investigator: Nathan Perlis, MD Sub-Investigator: Robert Hamilton, MD Sub-Investigator: Girish Kulkarni, MD Sub-Investigator: Alexandre Zlotta, MD Sub-Investigator: Antonio Finelli, MD Sub-Investigator: Srikala Sridhar, MD 收起 <<

CAS号	154229-19-3
分子式	C₂₄H₃₁NO
分子量	349.51
SMILES Code	[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C
MDL No.	MFCD00924100

别名	CB-7598
运输	蓝冰
InChI Key	GZOSMCIZMLWJML-VJLLXTKPSA-N
Pubchem ID	132971

hamster V79MZh11B1 cells		Function assay		Inhibition of human CYP11B1 expressed in hamster V79MZh11B1 cells, IC50=1.608 μM	18672868
PC3 cells		Cytotoxic assay	48 h	Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50=9.32 μM	24148837

Abiraterone/阿比特龙 {[allProObj[0].p_purity_real_show]}

Abiraterone/阿比特龙纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Abiraterone/阿比特龙质控信息

Abiraterone/阿比特龙生物活性

Abiraterone/阿比特龙细胞实验

Abiraterone/阿比特龙动物实验

Abiraterone/阿比特龙动物研究

Abiraterone/阿比特龙临床研究

Abiraterone/阿比特龙参考文献

Abiraterone/阿比特龙实验方案

Abiraterone/阿比特龙技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Dose	Mice: 200 mg/kg^[3]
Administration	p.o.

Abiraterone/阿比特龙 {[allProObj[0].p_purity_real_show]}

Abiraterone/阿比特龙 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Abiraterone/阿比特龙 质控信息

Abiraterone/阿比特龙 生物活性

Abiraterone/阿比特龙 细胞实验

Abiraterone/阿比特龙 动物实验

Abiraterone/阿比特龙 动物研究

Abiraterone/阿比特龙 临床研究

Abiraterone/阿比特龙 参考文献

Abiraterone/阿比特龙 实验方案

Abiraterone/阿比特龙 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Abiraterone/阿比特龙纯度/质量文件产品仅供科研

Abiraterone/阿比特龙质控信息

Abiraterone/阿比特龙生物活性

Abiraterone/阿比特龙细胞实验

Abiraterone/阿比特龙动物实验

Abiraterone/阿比特龙动物研究

Abiraterone/阿比特龙临床研究

Abiraterone/阿比特龙参考文献

Abiraterone/阿比特龙实验方案

Abiraterone/阿比特龙技术信息